🇺🇸 FDA
Pipeline program

JTT-861, Placebo tablet for JTT-861

AT861-G-22-002

Phase 2 small_molecule active

Quick answer

JTT-861, Placebo tablet for JTT-861 for Heart Failure (Heart Failure with Reduced Ejection Fraction) is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Heart Failure (Heart Failure with Reduced Ejection Fraction)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials